首页> 外国专利> APPLICATION OF SERUM PROTEIN HFREP1 IN DIAGNOSIS OF RHEUMATOID ARTHRITIS DISEASE STATE

APPLICATION OF SERUM PROTEIN HFREP1 IN DIAGNOSIS OF RHEUMATOID ARTHRITIS DISEASE STATE

机译:血清蛋白HFREP1在类风湿性关节炎疾病状态诊断中的应用

摘要

Provided is an application of a serum protein HFREP1 in the diagnosis of rheumatoid arthritis disease state. According to DAS28, a rheumatoid arthritis (RA) disease activity scoring system recommended by the European Anti-Rheumatism Alliance, the RA disease state is divided into an active phase and a remission phase. However, the DAS28 scoring system is a set of subjective scoring system, which requires high doctor experience. The serum protein HFREP1 has an extremely high diagnostic significance in the diagnosis and classification of rheumatoid arthritis in the active and remission phases, has high diagnosis accuracy. Compared with the existing DAS28 scoring system, the serum protein HFREP1 is objective and easy to operate, and can be used to prepare a diagnostic kit for the diagnosis and classification of rheumatoid arthritis in the active and remission phases.
机译:提供了血清蛋白HFREP1在类风湿性关节炎疾病状态的诊断中的应用。 根据DAS28,由欧洲抗风湿症联盟推荐的类风湿性关节炎(RA)疾病活动评分系统,RA病状态分为活性阶段和缓解阶段。 然而,DAS28评分系统是一组主观评分系统,需要高医生经验。 血清蛋白HFREP1在活性和缓解阶段的类风湿性关节炎的诊断和分类中具有极高的诊断意义,具有高的诊断精度。 与现有的DAS28评分系统相比,血清蛋白HFREP1是客观且易于操作的,可用于制备诊断套件,用于在活性和缓解阶段的诊断和分类类风湿性关节炎。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号